HIV-1 Nef mediates pak phosphorylation of Mek1 serine298 and elicits an active phospho-state of Pak2

Current HIV Research

Volumn 11, Issue 3, 2013, Pages 198-209

  Kouwenhoven, Arlette ^a   Minassian, Violette Der ^a   Marsh, Jon W ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Kinase; Mek; Nef; Pak; Phosphorylation; T cell

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; NEF PROTEIN; P21 ACTIVATED KINASE; P21 ACTIVATED KINASE 2; RAC PROTEIN;

ARTICLE; CELL ACTIVATION; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; GEL ELECTROPHORESIS; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

CELLS, CULTURED; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; MAP KINASE KINASE 1; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; P21-ACTIVATED KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; T-LYMPHOCYTES;

EID: 84880084846     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/1570162X113119990039     Document Type: Article

References (103)

1. Baur AS, Sawai ET, Dazin P, Fantl WJ, Chengmayer C, Peterlin BM. HIV-1 Nef leads to inhibition or activation of T-cells depending on its intracellular-localization. Immunity 1994; 1(5): 373-84.
2. Rhee SS, Marsh JW. HIV-1 Nef activity in murine T-cells-CD4 modulation and positive enhancement. J Immunol 1994; 152(10): 5128-34.
3. Mariani R, Skowronski J. CD4 down-regulation by Nef alleles Isolated from Human-Immunodeficiency-Virus Type 1-infected individuals. Proc Natl Acad Sci USA 1993; 90(12): 5549-53.
4. Chowers MY, Spina CA, Kwoh TJ, Fitch NJS, Richman DD, Guatelli JC. Optimal infectivity in-vitro of humanimmunodeficiency-virus type-1 requires an intact Nef gene. J Virol 1994; 68(5): 2906-14.
5. Schrager JA, Marsh JW. HIV-1 Nef increases T cell activation in a stimulus-dependent manner. Proc Natl Acad Sci USA 1999; 96(14): 8167-72.
6. Wang JK, Kiyokawa E, Verdin E, Trono D. The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc Natl Acad Sci USA 2000; 97(1): 394-9.
7. Fortin JF, Barat C, Beausejour Y, Barbeau B, Tremblay MJ. Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4(+) T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappa B, and AP-1 induction. J Biol Chem 2004; 279(38): 39520-31.
8. Fenard D, Yonemoto W, de Noronha C, Cavrois M, Williams SA, Greene WC. Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement. J Immunol 2005; 175(9): 6050-7.
9. Fackler OT, Lu XB, Frost JA, et al. P21-activated kinase 1 plays a critical role in cellular activation by Nef. Mol Cell Biol 2000; 20(7): 2619-27.
10. Manninen A, Huotari P, Hiipakka M, Renkema GH, Saksela K. Activation of NFAT-dependent gene expression by Nef: Conservation among divergent Nef alleles, dependence on SH3 binding and membrane association, and cooperation with protein kinase C-theta. J Virol 2001; 75(6): 3034-7.
11. Manninen A, Renkema GH, Saksela K. Synergistic activation of NFAT by HIV-1 Nef and the Ras/MAPK pathway. J Biol Chem 2000; 275(22): 16513-7.
12. Olivieri KC, Mukerji J, Gabuzda D. Nef-mediated enhancement of cellular activation and human immunodeficiency virus type 1 replication in primary T cells is dependent on association with p21-activated kinase 2. Retrovirology 2011; 8: 64.
13. Djordjevic JT, Schibeci SD, Stewart GJ, Williamson P. HIV type 1 Nef increases the association of T cell receptor (TCR)-signaling molecules with T cell rafts and promotes activation-induced raft fusion. AIDS Res Hum Retroviruses 2004; 20(5): 547-55.
14. Schibeci SD, Clegg AO, Biti RA, Sagawa K, Stewart GJ, Williamson P. HIV-Nef enhances interleukin-2 production and phosphatidylinositol 3-kinase activity in a human T cell line. AIDS 2000; 14(12): 1701-7.
15. Miller MD, Warmerdam MT, Gaston I, Greene WC, Feinberg MB. The human immunodeficiency virus-1 Nef gene-product-a positive factor for viral-infection and replication in primary lymphocytes and macrophages. J Exp Med 1994; 179(1): 101-13.
16. Spina CA, Kwoh TJ, Chowers MY, Guatelli JC, Richman DD. The importance of Nef in the induction of human-immunodeficiencyvirus type-1 replication from primary quiescent CD4 lymphocytes. J Exp Med 1994; 179(1): 115-23.
17. Wu YT, Marsh JW. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 2001; 293(5534): 1503-6.
18. Deronde A, Klaver B, Keulen W, Smit L, Goudsmit J. Natural HIV-1 Nef accelerates virus-replication in primary humanlymphocytes. Virology 1992; 188(1): 391-5.
19. Papkalla A, Munch J, Otto C, Kirchhoff F. Nef enhances human immunodeficiency virus type 1 infectivity and replication independently of viral coreceptor tropism. J Virol 2002; 76(16): 8455-9.
20. Li C, Lai CF, Sigman DS, Gaynor RB. Cloning of a cellular factor, interleukin binding-factor, that binds to NFAT-like motifs in the human-immunodeficiency-virus long terminal repeat. Proc Natl Acad Sci USA 1991; 88(17): 7739-43.
21. Yang ZY, Engel JD. Human T-cell transcription factor GATA-3 stimulates HIV-1 expression. Nucleic Acids Res 1993; 21(12): 2831-6.
22. Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmid RM, Nabel GJ. A cooperative interaction between NF-kappa-B and SP1 is required for HIV-1 enhancer activation. EMBO J 1993; 12(9): 3551-8.
23. Barry PA, Prattlowe E, Unger RE, Luciw PA. Cellular factors regulate transactivation of human-immunodeficiency-virus type-1. J Virol 1991; 65(3): 1392-9.
24. Jones KA, Peterlin BM. Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem 1994; 63: 717-43.
25. Stevenson M, Stanwick TL, Dempsey MP, Lamonica CA. HIV-1 replication is controlled at the level of T-cell activation and proviral integration. EMBO J 1990; 9(5): 1551-60.
26. Tongstarksen SE, Luciw PA, Peterlin BM. Signaling through lymphocyte-T surface-proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J Immunol 1989; 142(2): 702-7.
27. Perlmutter RM, Levin SD, Appleby MW, Anderson SJ, Alberolaila J. Regulation of lymphocyte function by protein-phosphorylation. Annu Rev Immunol 1993; 11: 451-99.
28. Weiss A, Littman DR. Signal-transduction by lymphocyte antigen receptors. Cell 1994; 76(2): 263-74.
29. Schrager JA, Minassian VD, Marsh JW. HIV Nef increases T cell Erk MAP kinase activity. J Biol Chem 2002; 277(8): 6137-42.
30. Choi HJ, Smithgall TE. HIV-1 Nef promotes survival of TF-1 macrophages by inducing Bcl-X-L expression in an extracellular signal-regulated kinase-dependent manner. J Biol Chem 2004; 279(49): 51688-96.
31. Witte V, Laffert B, Gintschel P, et al. Induction of HIV transcription by Nef involves Lck activation and protein kinase C theta raft recruitment leading to activation of Erk1/2 but not NF kappa B. J Immunol 2008; 181(12): 8425-32.
32. Pan XY, Rudolph JM, Abraham L, et al. HIV-1 Nef compensates for disorganization of the immunological synapse by inducing trans-Golgi network-associated Lck signaling. Blood 2012; 119(3): 786-97.
33. Neri F, Giolo G, Potesta M, Petrini S, Doria M. The HIV-1 Nef protein has a dual role in T cell receptor signaling in infected CD4(+) T lymphocytes. Virology 2011; 410(2): 316-26.
34. Li YQ, Hii CST, Der CJ, Ferrante A. Direct evidence that ERK regulates the production/secretion of interleukin-2 in PHA/PMAstimulated T lymphocytes. Immunology 1999; 96(4): 524-8.
35. Genot E, Cleverley S, Henning S, Cantrell D. Multiple p21ras effector pathways regulate nuclear factor of activated T cells. EMBO J 1996; 15(15): 3923-33.
36. Cobb MH, Goldsmith EJ. How MAP kinases are regulated. J Biol Chem 1995; 270(25): 14843-6.
37. Rubinfeld H, Seger R. The ERK cascade-A prototype of MAPK signaling. Mol Biotechnol 2005; 31(2): 151-74.
38. Yang XY, Gabuzda D. Regulation of human immunodeficiency virus type 1 infectivity by the ERK mitogen-activated protein kinase signaling pathway. J Virol 1999; 73(4): 3460-6.
39. Schlaepfer DD, Hanks SK, Hunter T, Vandergeer P. Integrinmediated signal-transduction linked to ras pathway by grb2 binding to focal adhesion kinase. Nature 1994; 372(6508): 786-91.
40. Moro L, Venturino M, Bozzo C, et al. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesiondependent cell survival. EMBO J 1998; 17(22): 6622-32.
41. Frost JA, Steen H, Shapiro P, et al. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. EMBO J 1997; 16(21): 6426-38.
42. Slack-Davis JK, Eblen ST, Zecevic M, et al. PAKI phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation. J Cell Biol 2003; 162(2): 281-91.
43. Eblen ST, Slack JK, Weber MJ, Catling AD. Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEKI-ERK complexes. Mol Cell Biol 2002; 22(17): 6023-33.
44. Coles LC, Shaw PE. PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway. Oncogene 2002; 21(14): 2236-44.
45. Beeser A, Jaffer ZM, Hofmann C, Chernoff J. Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors. J Biol Chem 2005; 280(44): 36609-15.
46. Sawai ET, Baur A, Struble H, Peterlin BM, Levy JA, Chengmayer C. Human-Immunodeficiency-Virus Type-1 Nef associates with a cellular serine kinase in T-lymphocytes. Proc Natl Acad Sci USA 1994; 91(4): 1539-43.
47. Nunn MF, Marsh JW. Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. J Virol 1996; 70(9): 6157-61.
48. Swingler S, Gallay P, Camaur D, Song JP, Abo A, Trono D. The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix. J Virol 1997; 71(6): 4372-7.
49. Wolf D, Witte V, Laffert B, et al. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med 2001; 7(11): 1217-24.
50. Wei BL, Arora VK, Raney A, et al. Activation of p21-activated kinase 2 by human immunodeficiency virus type 1 Nef induces merlin phosphorylation. J Virol 2005; 79(23): 14976-80.
51. Lee J-H, Wittki S, Brau T, et al. HIV Nef, Paxillin, and Pak1/2 Regulate Activation and Secretion of TACE/ADAM10 Proteases. Mol Cell 2013; 49(4): 668-79.
52. Stolp B, Reichman-Fried M, Abraham L, et al. HIV-1 Nef interferes with host cell motility by deregulation of Cofilin. Cell Host Microbe 2009; 6(2): 174-86.
53. Schindler M, Rajan D, Specht A, et al. Association of Nef with p21-activated kinase 2 is dispensable for efficient human immunodeficiency virus type 1 replication and cytopathicity in Ex vivo-infected human lymphoid tissue. J Virol 2007; 81(23): 13005-14.
54. Tan Y, Demeter MR, Ruan H, Comb MJ. BAD Ser-155 phosphorylation regulates BAD/Bcl-XL interaction and cell survival. J Biol Chem 2000; 275(33): 25865-9.
55. Yin TG, Sandhu G, Wolfgang CD, et al. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem 1997; 272(32): 19943-50.
56. Rena G, Guo SD, Cichy SC, Unterman TG, Cohen P. Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B. J Biol Chem 1999; 274(24): 17179-83.
57. Gatei M, Sloper K, Sorensen C, et al. Ataxia-telangiectasiamutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation. J Biol Chem 2003; 278(17): 14806-11.
58. Irish JM, Hovland R, Krutzik PO, et al. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004; 118(2): 217-28.
59. Garcia JV, Miller AD. Serine phosphorylation-independent downregulation of cell-surface CD4 by Nef. Nature 1991; 350(6318): 508-11.
60. Liu XX, Schrager JA, Lange GD, Marsh JW. HIV Nef-mediated cellular phenotypes are differentially expressed as a function of intracellular NEF concentrations. J Biol Chem 2001; 276(35): 32763-70.
61. Lifson JD, Reyes GR, McGrath MS, Stein BS, Engleman EG. AIDS retrovirus induced cytopathology-giant-cell formation and involvement of CD4 antigen. Science 1986; 232(4754): 1123-7.
62. Popovic M, Readconnole E, Gallo RC. T4 positive human neoplastic cell-lines susceptible to and permissive for HTLV-III. Lancet 1984; 2(8417): 1472-3.
63. Aiken C, Konner J, Landau NR, Lenburg ME, Trono D. Nef induces CD4 endocytosis-requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 1994; 76(5): 853-64.
64. Rhee SS, Marsh JW. Human-immunodeficiency-virus type-1 Nefinduced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. J Virol 1994; 68(8): 5156-63.
65. Nheu TV, He H, Hirokawa Y, et al. The K252a derivatives, inhibitors for the PAK/MLK kinase family, selectively block the growth of RAS transformants. Cancer J 2002; 8(4): 328-36.
66. Deacon SW, Beeser A, Fukui JA, et al. An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase. Chem Biol 2008; 15(4): 322-31.
67. Viaud J, Peterson JR. An allosteric kinase inhibitor binds the p21-activated kinase autoregulatory domain covalently. Mol Cancer Ther 2009; 8(9): 2559-65.
68. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L. A brain serine threonine protein-kinase activated by CDC42 and Rac1. Nature 1994; 367(6458): 40-6.
69. Chong C, Tan L, Lim L, Manser E. The mechanism of PAK activation-Autophosphorylation events in both regulatory and kinase domains control activity. J Biol Chem 2001; 276(20): 17347-53.
70. King CC, Bokoch GM, Reilly AM, et al. A GTPase-independent mechanism of PAK activation: Regulation by sphingosine and other biologically active lipids. J Leukoc Biol 1998: 273(14): 8137-44.
71. Loo TH, Ng YW, Lim L, Manser E. GITI activates p21-activated kinase through a mechanism independent of p21 binding. Mol Cell Biol 2004; 24(9): 3849-59.
72. Shutes A, Onesto C, Picard V, Leblond B, Schweighoffer F, Der CJ. Specificity and mechanism of action of EHT 1864, a novel small molecule inhibitor of rac family small GTPases. J Biol Chem 2007; 282(49): 35666-78.
73. Gao Y, Dickerson JB, Guo F, Zheng J, Zheng Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc Natl Acad Sci USA 2004; 101(20): 7618-23.
74. Janardhan A, Swigut T, Hill B, Myers MP, Skowronski J. HIV-1 Nef binds the DOCK2-ELMO1 complex to activate Rac and inhibit lymphocyte chemotaxis. PLoS Biol 2004; 2(1): 65-76.
75. Manninen A, Hiipakka M, Vihinen M, Lu W, Mayer BJ, Saksela K. SH3-Domain binding function of HIV-1 Nef is required for association with a PAK-related kinase. Virology 1998; 250(2): 273-82.
76. Wiskerchen M, Chengmayer C. HIV-1 Nef association with cellular serine kinase correlates with enhanced virion infectivity and efficient proviral DNA synthesis. Virology 1996; 224(1): 292-301.
77. Agopian K, Wei BL, Garcia JV, Gabuzda D. A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2. J Virol 2006; 80(6): 3050-61.
78. O'Neill E, Kuo LS, Krisko JF, Tomchick DR, Garcia JV, Foster JL. Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef. J Virol 2006; 80(3): 1311-20.
79. Iafrate AJ, Bronson S, Skowronski J. Separable functions of nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J 1997; 16(4): 673-84.
80. Saksela K, Cheng GH, Baltimore D. Proline-rich (pxxp) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of nef(+) viruses but not for down-regulation of CD4. EMBO J 1995; 14(3): 484-91.
81. Greenberg ME, Iafrate AJ, Skowronski J. The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J 1998; 17(10): 2777-89.
82. Craig HM, Pandori MW, Riggs NL, Richman DD, Guatelli JC. Analysis of the SH3-Binding region of HIV-1 Nef: Partial functional defects introduced by mutations in the polyproline helix and the hydrophobic pocket. Virology 1999; 262(1): 55-63.
83. Manser E, Huang HY, Loo TH, et al. Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol Cell Biol 1997; 17(3): 1129-43.
84. Walter BN, Huang ZD, Jakobi R, et al. Cleavage and activation of pal-activated protein kinase gamma-PAK by CPP32 (Caspase 3)-Effects of autophosphorylation on activity. J Biol Chem 1998; 273(44): 28733-9.
85. King CC, Gardiner EMM, Zenke FT, et al. P21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositidedependent kinase-1 (PDK1). J Biol Chem 2000; 275(52): 41201-9.
86. Gatti A, Huang ZD, Tuazon PT, Traugh JA. Multisite autophosphorylation of p21-activated protein kinase gamma-PAK as a function of activation. J Biol Chem 1999; 274(12): 8022-8.
87. Benner GE, Dennis PB, Masaracchia RA. Activation of an S6/H4 kinase (Pak-65) from human placenta by intramolecular and intermolecular autophosphorylation. J Biol Chem 1995; 270(36): 21121-8.
88. Chu PC, Wu J, Liao XC, et al. A novel role for p21-activated protein kinase 2 in T cell activation. J Immunol 2004; 172(12): 7324-34.
89. Lian JP, Toker A, Badwey JA. Phosphorylation of the activation loop of gamma p21-activated kinase (gamma-Pak) and related kinases (MSTs) in normal and stressed neutrophils. J Immunol 2001; 166(10): 6349-57.
90. Riley JL, Mao M, Kobayashi S, et al. Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors. Proc Natl Acad Sci USA 2002; 99(18): 11790-5.
91. Nukada Y, Okamoto N, Konakahara S, et al. AILIM/ICOSmediated elongation of activated T cells is regulated by both the PI3-kinase/Akt and Rho family cascade. Int Immunol 2006; 18(12): 1815-24.
92. Missy K, Hu B, Schilling K, et al. alpha PIX Rho GTPase guanine nucleotide exchange factor regulates lymphocyte functions and antigen receptor signaling. Mol Cell Biol 2008; 28(11): 3776-89.
93. Zhan Q, Ge QY, Ohira T, Van Dyke T, Badwey JA. P21-activated kinase 2 in neutrophils can be regulated by phosphorylation at multiple sites and by a variety of protein phosphatases. J Immunol 2003; 171(7): 3785-93.
94. Arora VK, Molina RP, Foster JL, et al. Lentivirus Nef specifically activates Pak2. J Virol 2000; 74(23): 11081-7.
95. Renkema GH, Manninen A, Mann DA, Harris M, Saksela K. Identification of the Nef-associated kinase as p21-activated kinase 2. Curr Biol 1999; 9(23): 1407-10.
96. Raney A, Kuo LS, Baugh LL, Foster JL, Garcia JV. Reconstitution and molecular analysis of an active human immunodeficiency virus type 1 Nef/p21-activated kinase 2 complex. J Virol 2005; 79(20): 12732-41.
97. Krautkramer E, Giese SI, Gasteier JE, Muranyi W, Fackler OT. Human immunodeficiency virus type 1 nef activates p21-activated kinase via recruitment into lipid rafts. J Virol 2004; 78(8): 4085-97.
98. Pulkkinen K, Renkema GH, Kirchhoff F, Saksela K. Nef associates with p21-activated kinase 2 in a p21-GTPase-dependent dynamic activation complex within lipid rafts. J Virol 2004; 78(23): 12773-80.
99. Sawai ET, Baur AS, Peterlin BM, Levy JA, Chengmayer C. A conserved domain and membrane targeting of Nef from HIV and SIV are required for association with a cellular serine kinaseactivity. J Biol Chem 1995; 270(25): 15307-14.
100. Rauch S, Pulkkinen K, Saksela K, Fackler OT. Human immunodeficiency virus type 1 nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity. J Virol 2008; 82(6): 2918-29.
101. Lu WG, Katz S, Gupta R, Mayer BJ. Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck. Curr Biol 1997; 7(2): 85-94.
102. Parrini MC, Camonis J, Matsuda M, de Gunzburg J. Dissecting Activation of the PAK1 Kinase at Protrusions in Living Cells. J Biol Chem 2009; 284(36): 24133-43.
103. Witte V, Laffert B, Rosorius O, et al. HIV-1 Nef mimics an integrin receptor signal that recruits the polycomb group protein Eed to the plasma membrane. Mol Cell 2004; 13(2): 179-90.